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ABSTRACT
Ruyi-Jinhuang Gao (RJG) is an ointment prepared from Ruyi-Jinhuang San (RJS), a traditional formula of powder-type Chinese
medicine, usually used in anti-inflammatory analgesic care in China. The present study is aimed to detect the anti-inflammatory
signaling of RJG exposed by an experimental model of lipopolysaccharides (LPS)-induced pro-inflammatory expression of inducible
nitric oxide synthase (iNOS) and prostaglandin endoperoxide synthase (PGH synthase-2, COX-2). LPS-induced activation of iNOS and
COX-2 has been recognized to increase cytokines and nitric oxide (NO), which play predominant roles in inflammation. In the culture
of RAW264.7 cells, RJG concentration-dependently inhibited LPS-induced iNOS and COX-2 expression. However, the herbal components of RJG displayed different results, including increase and decrease of both protein expressions. Among them, inhibition by
Curcuma Zedorarica Rhizoma (Cu), Atractylodis Lancea Rhizoma (At), and Glycyrrhizae Radix (Gl) are more potent than that by
others. Inhibition by Cu and At are associated with their cytotoxicity. Glycyrrhizae Radix (Gl), with lower cytotoxicity in comparison
with Cu and At, is the most potent component of RJG on inhibiting LPS-induced iNOS and COX-2 expression.
In comparison with LPS-induced tumor necrosis factor-α (TNF-α), croton oil-induced formation of TNF-α and interleukin-4 (IL4), RJG did not increase the pro-inflammatory cytokines. These facts indicated that RJG could not significantly sensitize an immunologic response during the treatment of non-wounded inflammation on body surface. Ruyi-Jinhuang Patch (RJP), a pharmaceutical
preparation of RJG, has proven to have significant relief of cutaneous inflammation-associated somatic pain in clinical use.
Key words: RJG, LPS, iNOS, COX-2, cytokines, anti-inflammation

INTRODUCTION
Ruyi-Jinhuang Gao (RJG) is an ointment prepared
from water and alcohol extracts of Ruyi-Jinhuang San
(RJS), a traditional formula of yellowish powder-type
Chinese medicine described in I-Tzong-Jin-Jiann. Its usage
is currently re-printed in the Pharmacopoeia of China
(Peijing, China, 2000). RJS has been used in local antiinflammatory analgesic care for patients with myofascial
pain, arthritis, trauma, frozen shoulder, tendonitis, and neuropathic and various somatic pains. It is a mixture of 10
herbs, including Trichosanthes Root (Tr, 320 parts),
Angelicae Dahuricae Radix (An, 160 parts), Phellodenri
Cortex (Ph, 160 parts), Rhei Rhizoma (Rh, 160 parts),
Curcuma Zedorarica Rhizoma (Cu, 160 parts), Glycyrrhizae
* Author for correspondence. Tel: +886-7-3121101 ext. 2243 ext. 11;
Fax: +886-7-3234686; E-mail: ingjun@kmu.edu.tw

Radix (Gl, 64 parts), Magnoliae Cortex (Ma, 64 parts),
Atractylodis Lancea Rhizoma (At, 64 parts), Arisaematis
Rhizoma (Ar, 64 parts), and Auranti Nobilis Pericarpium
(Au, 64 parts).
Lipopolysaccharides (LPS), the structural component
of the outer membranes of gram-negative bacteria(1), play a
pivotal role in the inflammatory response in in vivo and
have been used to induce inflammatory response mediated
by action on macrophage in in vitro. Croton oil, an
immunological sensitizer on skin, was described to initiate
cutaneous inflammation-like contact dermatitis and
cytokine release in mice plasma(2,3). In addition, it is
suggested that anti-inflammatory agents may inhibit the
immunologic response induced by croton oil during their
contact with dermis. However, unsuitable use of glucocorticoids may modulate the immune function in the skin
through aberrant production of tachykinin, such as
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substance P or other epidermal cell derived cytokines(4).
Chinese medicine is an useful alternative to prevent nonwounded inflammatory responses without sensitization
activity on body surface of patients. Animal studies have
reported that toxic actions of LPS and croton oil resulted in
the release of cytokines, especially tumor necrosis factor-α
(TNF-α, interleukin 1 (IL-1), interleukin 8 (IL-8) and interleukin 4 (IL-4). These cytokines drive a cascade of
mediators and lead to increase of NO(5,2). However, both
LPS-induced pro-inflammatory signaling in macrophage
and croton oil-induced dermatitis may provide useful information for patients desiring pain relief.
Macrophages have a central role in controlling inflammation because they can develop into cells that cause
further injury or facilitate tissue repair(6). When activated
by LPS, macrophages inhibit the growth of a wide variety
of invasive microorganisms through releasing nitric oxide
(NO), cytokines, TNF-α, and eicosanoid mediators of the
immune response(7,8,9). Many cytokines are involved in
inflammation. Under normal circumstances, local production of these mediators is precisely regulated by inducible
activation of iNOS and COX-2 and thus serves to orchestrate the inflammation pathway, including causing somatic
pain. Cutaneous hyperalgesia at the site of an injury can be
explained by sensitization of nociceptors. This sensitization
is likely to be due to local release of chemical mediators in
the inflamed area(10).
The aim of this study was to investigate whether RJG
can inhibit LPS-induced expression of nitric oxide synthase
(iNOS) and prostaglandin endoperoxide synthase (PGH
synthase-2, COX-2) in macrophage. We also hoped to
provide a model of pro-inflammatory signaling to explain
the anti-inflammatory benefits of RJS and RJG on unwounded inflammatory human body surface for pain relief.
The inhibition intensities of each plant components in RJG
on expression of iNOS and COX-2 were also compared.
Those results might provide the way to recreate a more
potent formula of RJG in the future.

MATERIALS AND METHODS
I. Animals
BALB/c derived male mice, weighing 22 ± 2 g were
provided by National Laboratory Animals Breeding and
Research Center (NLABRC, Taiwan). The animals were
housed in individually ventilated cages (IVC Racks, 36
Mini Isolator systems) under Specific Pathogen-Free (SPF)
conditions throughout the experiment. Each APEC® cage
was autoclave sterilized and contained 5 mice (in cm, 26.7
length × 20.7 width × 14.0 height), and then maintained in
a hygienic environment under controlled temperature (2224˚C) and humidity (60-80%) with 12 hr light/dark cycle.
The animals were given free access to sterilized lab. Chow
and sterilized disposal of animals were performed
according to the guide for the care and use of Laboratory

Animals (National Academy Press, Washington, DC, USA,
1996)(11).
II. Chemicals
LPS (E. coli serotype 026:B6 and E. coli 026:B6),
albumin bovine (BSA), aprotinin, bromophenol blue,
brilliant blue G, ethylene glycol-bis-tetraacetic acid
(EGTA), glycerol, leupeptin, phenylmethylsulfonyl fluoride
(PMSF), DMEM, FBS, penicillin G and streptomycin
were obtained from GIBCO/BRL Life technologics, Grand
Island, NY, USA. Anti-iNOS mAb and goat anti-mouse
IgG-HRP were obtained from BD Transduction
Laboratories, USA. Anti-COX-2 goat polyclonal IgG, antiactin goat polyclonal IgG and Donkey anti-goat IgG horseradish peroxide conjugate were obtained from Santa Cruz
Biotechnology (USA). Acetone was from Wako, Japan,
Croton Oil, Tween-20 and phosphate-buffer saline were
from Sigma (USA). Ethanol was from Merck, Germany.
Mouse IL-4 kit was from R & D System, USA. Mouse
TNF-α kit was from R & D System, USA. Test substance
RJG (6 mg/100 µL acetone/mouse), vehicle (100 µL
acetone/mouse) and croton oil (2%/100 µL acetone/mouse)
as positive control were applied topically to mice on preshaved back region and posterior surface of ear. The dosing
volume was 100 µL/mouse. RJG was extracted with a
solvent system (ethanol/distill water, 7/3, 200 mL) at room
temperature from dry RJS powder (100 g) for 1 week.
Obtained extracts were diluted to make up the expected
working solution of 0.30 mg/100 µL for RJG and 1.0
mg/100 µL for each plant component. LPS (10 mg) was
dissolved in distilled water (1.0 mL) and then diluted to 100
µg/mL with culture medium as stock solution. Extract was
placed on an aluminum foil chip over an electronic heater
to evaporate the solvent under a constant temperature (75 ±
5˚C) and RJG was weighed by an electronic balance. RJG
(0.30 mg/100 µL) was then further diluted with extraction
solvent into 0.06, 0.12, 0.18, 0.24 mg/100 µL by a
micropipette (Eppendorf®). All these dilutions of RJG (100
µL) were then mixed with cell culture (9.8 mL) and LPS
(10 µg/100 µL stock solution) to make up 10 mL in each of
100 mm culture dishes for incubation before Westen blot
experiments. The final concentration of LPS during incubation was 1.0 µg/mL. In test on cell survival, extract
of plant component (100 µL), LPS (100 µL), and cell
(800 µL) culture were mixed in each well (1.0 mL) of the
plates for incubation. RJS was purchased from Kaiser
Pharmaceutical Co., Ltd. (Tainan, Taiwan). Species
examination for each of the plant components in RJS
(Lot number: 363936; effective until 2007, Kaiser
Pharmaceutical Co., Ltd.) was confirmed by one of authors,
Dr. Ming-Hong Yen.
III. Cell Culture
As shown in a previous report(12), mouse macrophage
cell line RAW 264.7 was obtained from the American Type
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Culture Collection. Cells were cultured in DMEM medium
(10 mL), supplemented with 2 mM L-glutamine, antibiotics
(100 U/mL of penicillin and 100 U/mL of streptomycin)
and 10% heat-inactivated fetal bovine serum (GIBCO/BRL)
and maintained at 37˚C in a humidified incubator containing 5% CO2. Cells in the 2nd-7th passage were used for
the experiments.
IV. Western Blot Analysis
According to the previous report(12), RAW 264.7 cells
were cultured in a 100-mm plate in the presence of LPS
(1.0 µg/mL) and RJG for 6 hr and 15 hr, respectively. Cells
were washed, harvested, and homogenized. The lysate was
centrifuged at 15,000×g for 30 min, and the supernatant
was freeze-dried. Using 8% SDS-polyacrylamide minigels
and transferring to immobilon polyvinylidene difluoride
membranes (Millipore, Germany), the membrane was
incubated overnight at 4˚C with 1% BSA and then
incubated with anti-iNOS (N32030, Transduction
Laboratory, USA), anti-COX-2 and anti-β-actin antibodies
(Santa Cruz Biotechnology Inc, USA). Expression of
protein was detected by enhanced chemiluminescence
(ECL) using Hyperfilm and ECL reagent (Amersham, UK).
V. Cytotoxicity and Cell Viability
According to the method of Mosmann(13), RAW 264.7
cells were plated at a density of 1 × 105 cells/well into
24-well plates. After overnight growth, cells were treated
with a different concentration of RJG for 6 and 15 hr. The
cytotoxic effect of the mentioned agents was evaluated
with the MTT assay. 3-(4,5-Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) was dissolved in PBS
at a concentration of 5 mg/mL and filtered with Millipore.
From the stock solution, 100 µL per 1 mL of medium was
added to each well, and plates were gently shaken and
incubated at 37˚C for 4 hr. Treatment of living cells with
MTT produced dark blue formazan product, whereas no
such staining was observed in dead cells. After loading
with MTT, the medium was replaced with 1 mL of acidified
β-isopropanol and shaken for 20-30 min at room temperature for color development. The 96-well plate was then
read with an enzyme-linked immunosorbent assay reader
(570 nm) to obtain the absorbance density values.
VI. Serum Immunoreactivity
In order to determine whether RJG possesses sensitization activity, serum IL-4 and TNF-α levels were measured
in BALB/c mice after application of RJG (6 mg/100 µL
acetone/mouse). In contrast, croton oil, as a reference sensitizer, was also administered topically at a dose of 6
mg/mouse onto the pre-shaved back region and posterior
ear surface of test mice. Serum IL-4 and TNF-α levels
were measured at 5 and 24 hr after application.

VII. Patients for Pain Relief
A total of 45 patients suffering from various somatic
pains were enrolled in the clinical evaluation of RuyiJinhuang Patch (RJP, Sinlix Ruyi ® Patch, Sinlix
Technologic Co., Kaohsiung, Taiwan), a preparation of RJG
for pain relief. Those patients with somatic pain received
RJP patch on the pain site. The following observations
were recorded: pain pattern, pain sites, pain intensity shown
by visual analog scale (VAS) before and after treatment,
subjective feeling after patching, and side effect.
A patch of regular size (4 × 6 inches) was used for
this study. Each patch was fixed at the pain site for 2 days.
The maximum number of sites to be patched was 3. If
exceeding 3 pain sites, patients would be excluded from
the study. Patients were requested to fill the form for the
evaluation of pain relief at 0, 0.5, 1, 4, 8, 16, 24, and 48 hr
after patching.
VIII. Statistics
All values were expressed as mean ± SEM. Student’s
t-test was applied to paired or unpaired observations. A
probability value (P) of less than 0.05 was considered to be
significant. In some figures the error bars fell within the
symbol size. Whenever a control group was compared with
more than one treated group, one-way ANOVA or two-way
repeated measures ANOVA was used. Statistical analysis
was performed by ANOVA followed by the Bonferroni correction for comparison of multiple means. Analysis of the
data and plotting of the figures were done with the aid of
software (SigmaStat and SigmaPlot, Version 5.0, San
Rafael, CA, USA; GraphPad PRISMTM, Version 2.0, San
Diego, CA, USA) run on an IBM compatible computer.

RESULTS
I. iNOS Expression
After LPS (1.0 µg/mL) treatment on RAW 264.7 cells
for 6 hr, iNOS protein considerably increased in these cells,
in comparison with vehicle control group (CTL). Cotreatment of cells with LPS (1.0 µg/mL) and RJG (0.06,
0.12, 0.18, 0.24, and 0.30 mg/mL) for 6 hr significantly
inhibited iNOS protein induction in RAW 264.7 cells
(Figure 1). Extracts of each herbal component of RJG
displayed various inhibition activities on LPS-induced
iNOS expression at 6 hr and 15 hr, respectively. Ph, Ma,
Rh, Gl, Cu, and At effectively inhibited LPS-induced iNOS
expression at 6 hr. However, at 15 hr, Ph, Gl, Cu, and At
were more potent in inhibiting the expression (Figure 4).
II. COX-2 Expression
RAW 264.7 macrophages cells did not express
detectable COX-2 protein when they were incubated with
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medium without LPS for 6 and 15 hr. After LPS (1.0
µg/mL) treatment for 6 and 15 hr, COX-2 protein substantially increased in these cells. Co-treatment of cells with
LPS (1.0 µg/mL) and RJG (0.24 and 0.30 mg/mL) for 15 hr
significantly inhibited COX-2 protein induction in RAW
264.7 macrophages; all concentrations of RJG treatment for
6 hr ineffectively inhibited COX-2 (Figure 2). At 6 hr, Tr,
Ar, Gl, Cu, and At were more potent in inhibition; however,
at 15 hr, Cu, At and Gl, were more potent in inhibiting
LPS-induced-COX-2 expression (Figure 5).

Moreover, Cu and At significantly decreased the survival
rate not only at 6 hr, but also at 15 hr (Figure 6). Gl
possessed lower cytotoxicity than Cu and At.
IV. Immunologic Safety
As shown in Figure 5A and B, no significant effects
on serum IL-4 or TNF-α levels were observed for RJG (6
COX-2 6 hr 씮
β-actin 6 hr 씮

Examination of cell viability or cytotoxicity in RAW
264.7 macrophages by MTT assay indicated that RJG at
0.12-0.30 mg/mL significantly affected the viability of
RAW 264.7 cells cultured at 6 hr. On the other hand, RJG
decreased the cell viability to about 80% at 0.30 mg/mL.
After incubation with cells for 15 hr, RJG concentrationdependently decreased the cell viability and at 0.30 mg/mL
up to about 50% (Figure 3). In contrast, each herbal extract
(1.0 mg) exerted different effects on viability in cell culture
(1.0 mL) at 6 hr and 15 hr, respectively. The components
Tr, Ar, and Au moderately increased the survival rate; Ph,
Cu, At and Gl, decreased the survival rate at 15 hr.

COX-2 15 hr 씮
β-actin 15 hr 씮
120

Relative COX-2 intensity (%)

III. Cell Viability or Cytotoxicity
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*
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Figure 2. Representative Western blots data depicting protein expression of COX-2 at 6 and 15 hr in the RAW 264.7 cell culture, in the
presence of vehicle control (CTL) or RJG and LPS 30 min prior to
them. Densitometry analyses are presented as the relative ratio of
COX-2 protein/β-actin protein. Data are expressed as means ± SEM.
*p < 0.05 (n = 3) were compared with LPS group, ANOVA followed
by Dunnett’s test.
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Figure 1. Representative Western blots data depicting the protein
expression of iNOS at 6 and 15 hr in the RAW 264.7 cell culture, in
the presence of vehicle control (CTL) or RJG and LPS 30 min prior
to them. Densitometry analyses are presented as the relative ratio of
iNOS protein/β-actin protein. Data are expressed as means ± SEM. *
p < 0.05 and **p < 0.01 (n = 3) were compared with LPS group,
ANOVA was followed by Dunnett's test.
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Figure 3. Cell survival rate caused by RJG. RAW 264.7 cells were
incubated with vehicle control (CTL) or RJG for 6 and 15 hr and
followed by MTT test. Data are expressed as means ± SEM. *p <
0.05 and **p < 0.01 (n = 3) were compared with CTL group.
ANOVA was followed by Dunnett's test.
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Figure 4. Representative Western blots data depicting protein expression of iNOS at 6 and 15 hr. Herbal components were incubated with
RAW 264.7 cells, in the presence of vehicle control (CTL) or each
herbal extract and LPS 30 min prior to them. Densitometry analyses
are presented as the relative ratio of iNOS protein/β-actin protein.
Data were obtained from three independent experiments and
expressed as means ± SEM. *p < 0.05, **p < 0.01 and ***p < 0.001
(n = 3) were compared with LPS group. ANOVA was followed by
Dunnett’s test.
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Figure 6. Cell survival rate caused by herbal extracts. RAW 264.7
cells were incubated for 6 and 15 hr in the presence of vehicle control
(CTL) or each herbal extract and then measured by MTT assay.
Abbreviation of plant components are the same as in Figure 5. Data
are expressed as means ± SEM. *p < 0.05 and **p < 0.01 (n = 3)
were compared with control group. ANOVA was followed by
Dunnett’s test.
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Figure 5. Representative Western blots data depicting protein expression of COX-2 at 6 and 15 hr in the culture of macrophage cell line
RAW 264.7, in the presence of vehicle control (CTL) or each herbal
extract (abbreviated in text) and LPS 30 min prior to them.
Densitometry analyses are presented as the relative ratio of COX-2
protein/β-actin protein. Data were expressed as means ± SEM. *p <
0.05, **p < 0.01 and ***p < 0.001 (n = 3) were compared with that
of LPS group. ANOVA was followed by Dunnett’s test.
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Figure 7. Immunologic sensitization response to RJG, croton oil, and
vehicle, applied topically on each test animal. LPS was administered
intravenously as positive control. Blood sample of each animal was
collected at 5 and 24 hr after the treatment. Plasma IL-4 (A) and
TNF-α. (B) levels were determined by ELISA assay. Unpaired
Student’s t test is applied for comparison between treated and vehicle
groups. Differences are considered insignificant (n = 3).
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mg/mouse) and croton oil (6 mg/mouse), compared to the
vehicle control group at 5 and 24 hr post-treatment.
Contact of croton oil with mouse ear dermis induced an
increase of cutaneous inflammation but could not increase
serum IL-4 and TNF-α (Figure 7). Intravenous LPS at 60
mg/kg certainly induced a significant (p < 0.05) increase
in serum TNF- α relative to the vehicle control group
(Figure 8).

Table 1. Pain relief effects of Ruyi-Jinhuang Gao after patching
Time after patching (hr)
VAS (pain score)
0
7.3 ± 2.1
0.5
7.1 ± 1.8
1
5.3 ± 2.4
4
3.5 ± 1.4*
8
3.8 ± 1.7*
12
4.3 ± 1.5*
16
5.8 ± 2.4
*Significantly different from that at 0 time (p < 0.05, paired t-test).

V. Clinical Finding
The demographic distribution of these patients,
including sex (male/female = 18/27) and age (49.5 ± 13.8
year), were insignificantly different. All the cases received
RJP without significant difference among them. The pain
pattern of the patients including pain chronicity, tentative
cause of pain, number of pain sites, and location of pain
sites were as follows: upper limb (36%); back (27%); lower
limb (22%); and neck (18%). The pain relief effect of
patients was found to be significantly different from that at
start time (p < 0.05, paired t-test) after 4 hr of patching and
this trend continued up to 12 hr (Table 1). The presence
(89%) of warming effect after patching was noted in all
patients. The onset time of feeling warmth after patching is
16.8 ± 7.8 min; the duration of the warming effect lasted
for 155.7 ± 6.2 min. The side effects caused by patching of
RJG were minimally found with localized purities and skin
rash (2%). Finally, the degree of satisfaction (91%) was
noted to be significant.

DISCUSSION
Local myofascial, arthritic, traumatic, shoulder, tendonitis, and neuropathic pains are un-wounded inflammatory somatic pain responses felt by patients near the body
surface. The hydrophilic ointment RJG, dressed on a semiplastic cloth, combines herbal extracts of RJS with pharmaceutical recipients, such as vegetable oil ester, fatty acid,
water, and various natural and semi-synthetic cellulose. In
contrast, in the practice of clinical therapy performed by
Chinese Medicine practitioners, RJS is traditionally mixed
with cold water, dressed on a gauze and applied together to
the somatic surface of the painful muscle of patients.
Newly formulated RJP has proven to be clinically useful in
easing pains without significant itchy response on the skin.
Our clinical observation showed that RJP was with longlasting anti-inflammatory analgesic benefits for 12-24 hr.
RJS and RJG, which inhibit iNOS expression resulting
in decrease of NO generation, may have beneficial therapeutic effects in the treatment of diseases due to overproduction of NO(7,8,12). Our results indicated RJG significantly inhibits iNOS and moderately inhibits COX-2 expression
in LPS-treated macrophages in a concentration- and timedependent manner (Figures 1 and 2). However, RJG did
not significantly induce dermal inflammation associated
cytokine (IL-4 and TNF-α). formation (Figure 7). Thus,

RJG may be safe and useful in the prevention and treatment
of inflammation-associated expression of iNOS and COX-2
in macrophage existing within a non-wounded body surface
(Figures 1 and 2).
All components of RJG displayed inhibition activities
on the expression of iNOS and COX-2 at 6 and 15 hr
(Figures 4 and 5). Among these, Ph, Ma, Rh, Gl, Cu, and
At were more potent in inhibiting iNOS expression (Figure
4), Tr and Ar were more potent in inhibiting COX-2
expression at 6 hr (Figure 5). At 15 hr, Ph, Ma, Rh, Gl,
Cu, and At were more potent in inhibition of iNOS expression; Tr, Ar, Ph, Ma, Gl, Cu, and At were more potent in
inhibiting COX-2 expression (Figures 4 and 5). Gl, Cu,
and At significantly inhibited the expression of iNOS and
COX-2 at 15 hr, indicating they were more potent than
other herbal plants in protecting against LPS-induced
inflammatory signalling. Since Cu and At also reduced the
survival rate of macrophage, implying that inhibition of
iNOS and COX-2 caused by Cu and At was partly
dependent on cytotoxicity. Thus, inhibition on LPS-induced
iNOS expression by RJG was also partly dependent on
cytotoxicity of Cu and At (Figure 6). Gl inhibited both
iNOS and COX-2 expression without inducing cytotoxicity
at 6 hr and so was obviously the most promising and
important anti-inflammatory herbs in RJG (Figures 4 and
5). Inflammation was mediated by multiple mediators,
which caused a series of pathologic events, including local
edema formation, increased vascular permeability, and
feeling pain. It was suggested that different herbs in RJG
may displayed various anti-inflammatory activities at
different stages of processing inflammation.
MTT test indicated that RJG caused less cytotoxicity
at 6 hr and higher cytotoxicity at 15 hr (Figure 6). The
components Cu and At at 6 hr and Ph, Ma, An, Gl, At at 15
hr decreased the survival rate of macrophage cell culture.
Among these components, Ph, Gl, Cu, and At were more
obviously potent than others in terms of cytotoxicity. In
contrast, Tr, Ar, and Au insignificantly increase the survival
rate indicating that they are not cytotoxic (Figure 6).
RJG is not only cytotoxic, but also anti-inflammatory,
evidenced from inhibition of iNOS and COX-2 expression
after incubation with LPS in macrophages cell line. The
anti-inflammatory outcome of RJG may be explained as
follows: (1) the presence of anti-inflammatory herbal components Gl, Cu, and At suppress the pro-inflammatory
signaling, iNOS and COX-2; (2) Tr, Ar, and Au protect
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against cell death; and (3) the cytotoxic effect was suppressed by other herbal components.
We demonstrate that RJG is an immune modulator
that reduces pro-inflammatory iNOS and COX-2 in LPStreated macrophages. RJG did insignificantly increase
TNF-α and IL-4 after contact with the dermis, indicating it
did not sensitize an immunologic response. Croton oil was
used as control in mice to cause ear edema, but it also
could not significantly increase TNF- α and IL-4(3,14,15).
The feeling of warmth induced by RJG was suggested to be
due to sensory neuron activation on skin caused by
pungency of Cu.
Clinical evidence show that patients feel satisfaction
after patching of RJG. Although we can not test directly on
macrophages of patients, our in vitro results from cell
culture implicate the pro-inflammatory response in vivo.
Further investigation on transdermal absorption of RJG
would be our next challenge.

CONCLUSIONS
Inhibiting activities on pro-inflammatory iNOS and
COX-2 expression in macrophages and lack of cytokine
formation in plasma by RJG may indicate its utility in
painful musculoskeletal conditions to relieve somatic pain.
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